VASTCON
VastCon Inc. is a biotech company developing early screening and diagnostics for cancer. VastCon was founded in 2011 by Drs. Anuraag Shrivastav and Shailly Varma Shrivastav and is headquartered in Winnipeg, Manitoba, Canada. The company includes a team of basic research scientists with the mandate to take research from the laboratory to bedside. VastCon’s lead product is a novel blood test for the early detection and screening of colorectal cancer. Colorectal cancer is the second or third leading cause of death due to cancer world-wide, despite being one of the most curable cancers if detected early. Unfortunately for many people, by the time it is detected it is already at an advanced stage leading to death.
VASTCON
Social Links:
Industry:
Biotechnology
Founded:
2011-01-01
Address:
Winnipeg, Manitoba, Canada
Country:
Canada
Website Url:
http://www.vastcon.com
Total Employee:
1+
Status:
Closed
Contact:
(204)416-8256
Email Addresses:
[email protected]
Total Funding:
25 K USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon Amazon SSL By Default Office 365 Mail GoDaddy DNS AWS Global Accelerator GoDaddy SSL
Similar Organizations
NextVivo
NextVivo is a biotech company developing an immune organoid technology platform.
Siva Therapeutics
Siva Therapeutics is a biotechnology company developing nanotechnology approaches for treating cancer.
Current Employees Featured
Founder
Investors List
VA Angels
VA Angels investment in Seed Round - VastCon
Official Site Inspections
http://www.vastcon.com
- Host name: a904c694c05102f30.awsglobalaccelerator.com
- IP address: 76.223.54.146
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "VastCon"
VastCon - Crunchbase Company Profile & Funding
VastCon Inc. is a biotech company developing early screening and diagnostics for cancer. VastCon was founded in 2011 by Drs. Anuraag Shrivastav and Shailly Varma Shrivastav and …See details»
VastCon Inc
Develop novel diagnostics and therapeutics for metastatic cancers using proprietary molecular signatures. Copyright © 2024 VastCon Inc - All Rights Reserved.See details»
Overview - VastCon Inc
Vastcon has identified unique molecular signatures for metastatic cancers that provide critical insights into disease progression and prognosis. These insights provide the basis for new …See details»
Mangement - VastCon Inc
Biotechnology executive with over 30 years industry experience in drug discovery and development.See details»
Vastcon Inc Company Profile | Winnipeg, MB, Canada
Find company research, competitor information, contact details & financial data for Vastcon Inc of Winnipeg, MB. Get the latest business insights from Dun & Bradstreet.See details»
OncoDrex - LinkedIn
OncoDrex is a biotech company developing early screening and diagnostics for cancer. OncoDrex's lead product is a novel blood test for the early detection and screening of …See details»
VastCon - Products, Competitors, Financials, Employees, …
VastCon works as a biotechnology company focused on developing diagnostics and therapeutics for metastatic cancers. The company works on molecular signatures for the screening and …See details»
Vastcon - Overview, News & Similar companies | ZoomInfo.com
VastCon Inc. is a biotech company developing early screening and diagnostics for cancer. VastCon was founded in 2011 by Drs. Anuraag Shrivastav and Shailly Varma Shrivastav and …See details»
OncoDrex Company Profile - Craft
OncoDrex (formerly known as VastCon) is a biotech company developing early screening and diagnostics for cancer. Its lead product is a blood test that detects colorectal cancer. …See details»
VastCon - Crunchbase
VastCon Inc. is a biotech company developing early screening and diagnostics for cancer.See details»
VastCon - Funding, Financials, Valuation & Investors - Crunchbase
VastCon Inc. is a biotech company developing early screening and diagnostics for cancer.See details»
VastConis - VentureRadar
Website: http://vastcon.com/ VastCon Inc. is an oncology company focused on developing simple biomarker(s) based tests for cancers: Screening; Diagnostic; Predictive; Companion tests. …See details»
Shailly Varma - President and Co-Founder - VastCon - LinkedIn
Co-Founder and Chief-scientific Officer at Oncodrex · Experience: VastCon · Education: University of Hyderabad · Location: Winnipeg · 99 connections on LinkedIn. View Shailly …See details»
VastCon - Updates, News, Events, Signals & Triggers - Crunchbase
VastCon Inc. is a biotech company developing early screening and diagnostics for cancer.See details»
New cancer screening test could save lives - University of …
Sep 16, 2021 · The original proof-of-concept study included 74 patients, but now they are planning a confirmatory trial of 650 patients with industry partner VastCon, who is developing …See details»
Scientific Advisors - VastCon Inc
Develop novel diagnostics and therapeutics for metastatic cancers using proprietary molecular signatures.See details»
VastCon - Tech Stack, Apps, Patents & Trademarks - Crunchbase
VastCon Inc. is a biotech company developing early screening and diagnostics for cancer.See details»
VastCon - Contacts, Employees, Board Members, Advisors & Alumni
VastCon has 2 current employee profiles, including President & Co-Founder Anuraag Shrivastav. VastCon Inc. is a biotech company developing early screening and diagnostics for cancer.See details»
BC Screening - VastCon Inc
Oncodrex’s Predictive Diagnostics remove the fear of “WHAT IF COMES BACK” by predicting the likelihood of HR+ breast cancer recurrence. The IHC based predictive test could easily be …See details»
Shailly Varma - Co-Founder and Chief Scientific Officer @ VastCon ...
Shailly Varma is the Co-Founder and Chief Scientific Officer of VastCon.See details»